Clinical Trial Update: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

AstraZeneca is conducting a Phase 1/2 trial to evaluate the safety of AZD6750 in adults with select advanced or metastatic solid tumors; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Gastric Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Merkel Cell Carcinoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• AZD6750

Snippet

Sponsor: AstraZeneca | Conditions: Melanoma, Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING